Argos Soditic acquires Natural Distribution for an undisclosed amount. Argos Soditic, an independent European private equity group with offices in Geneva, Paris and Milan, disclosed to the public that it acquired the National Distribution Group.
Healthcare Health/Fitness
Valeant Acquires Actavis
Valeant Pharmaceuticals is in discussion to acquire Actavis for about US$13 billion. Valeant Pharmaceuticals International Inc, the largest publicly listed drug maker in Canada, is in discussion to purchase generics pharmaceutical firm Actavis Inc for US$13 billion.
Horizon Tech Finance Grants US$2M Loan to New Haven Pharma
Horizon Tech provides New Haven Pharma a US$2 million loan. It was announced today that New Haven Pharma was able to secure a US$2 million venture loan from Horizon Technology Finance.
Quintiles Set for IPO
Quintiles set for IPO worth an estimated at US$748.6 million. The largest service provider of testing services to pharmaceutical companies, Quintiles Transnational Holdings is expecting to price its shares between US$36 and US$40 for its public listing.
Carestream Bidders Down to Two
Only two private equity firms are in the running for Onex Corp's Carestream Health Inc as others pulled out citing uncertain outlook for the company's future.
Latest News
Funding for Genticel's HPV raises Eur18.2 million. Genticel, a biopharmaceutical company that develops original vaccines for patients who are contaminated with the human papillomavirus, announced today that it was able to secure Eur18.
In a proof of expansion, OPKO Health has acquired Prolor Biotech reportedly for US$480 million. OPKO Health Inc has announced that it would purchasing Prolor Biotech Inc, the biopharmaceutical ecompany from Israel through an all-stock deal that is estimated to be worth US$480 million.
Cervel Neurotech completes funding and raises US$14.1 million. Cervel Neurotech disclosed in an announcement today the completion of its funding round and its raising of US$14.
GSK would form a joint venture partnership with Avalon Ventures to provide financial and technical support to drug-discovery start up companies.
A consortium led by CEO Jing Lou and CPEChina Fund Ltd has made a higher bid for 3SBio. 3SBio, a biotechnology company from China that focuses on research, development, manufacture and marketing of biopharmaceutical products, has announced the receipt of a proposal letter from CPEChina Fund LP.
Elan rejects takeover bid of Royalty Pharma, saying it grossly undervalued the firm. The board of directors of Elan, the Irish pharmaceutical company has unanimously rejected the formal bid from Royalty Pharma.
Aamal and Vivantes agree to form healthcare joint venture. Aamal Company, the Qatari conglomerate has entered into a joint venture agreement with Vivantes International Medicine, the largest hospital consortium from Germany.
NovoPedics obtains funding from Foundation Venture Capital. The recently established NovoPedics was able to obtain a $500,000 funding from Foundation Venture Capital.
OPKO Health announced investment in OAO Pharmasynthez and partnership with Rusnano. OPKO Health Inc has announced that it would be investing about US$9.
